
Roche joins race for obesity drugs with $2.7 bln Carmot deal – ET HealthWorld | Pharma
New Delhi: Roche agreed to take over obesity drug developer Carmot Therapeutics for $2.7 billion, joining a list global contestants seeking to challenge the dominant...